CRC Interventional Oncology
Interventional oncology consists of image guided procedures which directly treat solid tumors. These procedures are typically performed in patients whose colorectal cancer has metastasized to the liver. Approximately 20% to 34% of patients will have metastatic colorectal cancer when diagnosed and 50% to 60% of patients diagnosed with non-metastatic disease will develop colorectal metastases over time.1 Metastatic disease most often develops more than 6 months after local or regional treatment with the liver being the most common site.
Interventional image-guided procedures provide minimally invasive alternatives for select patients with a few small metastases in accessible locations.2 Potential interventional oncology procedures include both percutaneous and transarterial endovascular approaches which are used in the following settings:
Neoadjuvant setting (prior to surgery) – treatment for unresectable tumors in patients with limited metastatic tumor burden or used to reduce the size of tumors to make them potentially resectable by surgery.
Adjuvant setting (following surgical resection of a tumor) – used in combination with chemotherapy to destroy any remnant tumor in select patients.
Salvage setting – for patients who have not been able to achieve successful treatment following chemotherapy.
Surgical resection of colorectal liver metastases remains the preferred treatment option as a result of better outcomes compared to interventional ablative approaches with the potential exception of small metastases.3 Minimally invasive interventional oncology procedures are often used to treat tumors which cannot be resected by surgery or for tumors in patients who are poor candidates for surgery due to medical issues.
resected by surgery or for tumors in patients who are poor candidates for surgery due to medical issues.
Percutaneous ablative procedures
Percutaneous ablative techniques include both thermal and non-thermal approaches. Thermal approaches include heat-based procedure (radiofrequency and microwave ablation) and cold-based procedures (cryoablation). Thermal ablative techniques have been shown to be effective in the local treatment of tumors and are associated with a low recurrence rate. Irreversible electroporation is currently the only non-thermal ablative approach. These are described in more detail below.
While ablation and resection are potentially curative options for metastatic CRC, only around 20% of patients are eligible for these treatments. Endovascular transarterial approaches provide an alternative treatment option for patients who are not candidates for surgical or percutaneous ablative procedures. Endovascular transarterial treatments use a minimally invasive approach and use image-guidance to deliver therapy into small hepatic arteries that provide the blood supply to the tumor in the liver. These procedures are performed in patients with metastatic CRC who are not candidates for surgical or percutaneous ablative procedures or for patients who are not responsive to therapy, have disease progression or toxicity to systemic chemotherapy. While these procedures are not curative, they can improve survival and improve quality of life.
Examples of endovascular transarterial procedures include: